1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
677E9660953497DC00025893C002A4BDD
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-omnichannel-engagement-in-medical-affairs-trends-drivers-implementation?opendocument
18
19opendocument
2044.201.97.138
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB
Access. Intelligence. Excellence

| Advanced Search | 0
Research and Consulting Areas of Expertise

Benchmarking Reports Areas of Expertise Report Catalog FAQ
Best Practice Database Areas of Expertise New Research Case Analogs Benefits Types Of Research Current Members
Research and Advisory Services Areas of Expertise Digital Technology Consortium Field Medical Excellence Medical Affairs Consortium White Papers Research Partners Partnership Benefits Contact Us
Excellence Services Pharma and Medical Device Quality New Product Planning Medical Affairs Pharmaceutical Launch Market Research Competitive Intelligence

Industries

Biotechnology Financial Services Healthcare Medical Device Manufacturing Pharmaceuticals Technology and Communications

Functions

Brand Management & Product Leadership Competitive & Business Intelligence Commercial Operations Customer Service Clinical Operations Digital Technologies / AI Human Resources Medical Affairs Market Access Market Research, Analytics & Forecasting

 

Marketing Management Patient Access, Support, Insights and Operations Product Launch Pull Through Pharma Launch Playbook Scenario Planning / War Gaming Sales Supply Chain
Corporate Overview About Benchmarking Benchmarking Books What is a Best Practice? Research Methodology

Our Clients Testimonials

Our Team Careers Best Practices Interns Work at Best Practices, LLC Help Set Research Agenda
Follow Best Practices LLC linkedIn twitter slideshare youtube pinterest

Overview Press Releases Speaking Events Media Coverage Receive Research Updates Contact Us
Address/Email/Phone Schedule a Meeting
Report Catalog Videos
Database Member Home RAS Member Home

» Products & Services » » Medical Affairs » Medical Affairs Excellence

Omnichannel Engagement in Medical Affairs: Trends, Drivers and Implementation

DB Image

Download FREE Excerpt

ID: 5747

Features:

10 Info Graphics

13 Data Graphics

160+ Metrics

12 Narratives

Pages/Slides: 29

Published: 2023

Delivery Format: Online PDF Document

 

License Options:


Buy Now

 

919-403-0251
Schedule a Meeting
Request a Quote


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Omnichannel Engagement in Medical Affairs: Trends, Drivers and Implementation”

STUDY OVERVIEW

The accelerated adoption of digital solutions by biopharma companies provides unprecedented opportunities for Medical Affairs to deliver a consistent, personalized experience to stakeholders by adopting an omnichannel approach to engagement. To ensure a seamless stakeholder experience across all channels, it is important to identify the current trends and drivers of omnichannel engagement.

Best Practices, LLC conducted this benchmarking research to examine Medical Affairs’ advances in omnichannel engagement. This study examines current levels, trends, and drivers of omnichannel engagement in Medical Affairs. It also identifies the key benefits, challenges, and lessons learned in implementing omnichannel engagement programs.

KEY TOPICS

  • Current Use of Omnichannel in Medical Affairs
  • Omnichannel Maturity Levels
  • Drivers of Omnichannel Engagement Plans
  • Omnichannel Benefits and Challenges

KEY METRICS

  • Which best describes Medical Affairs group's current approach to omnichannel engagement?
  • Please indicate the level of omnichannel engagement of the Medical Affairs function
  • Which of the listed customer groups are engaged in omnichannel programs?
  • How important are each of the main drivers in leading benchmark organizations to create an omnichannel engagement plan?
  • During the past three months, what percentage of engagement has been omnichannel?

SAMPLE KEY FINDINGS

  • Current use of omnichannel in Medical Affairs: 83% of surveyed biopharma manufacturers have already implemented some form of an omnichannel engagement program within Medical Affairs. Another 15% are planning to do so. Just 2% have no plans to adopt an omnichannel model.

METHODOLOGY

Best Practices, LLC engaged 57 leaders from 43 biopharma companies in this research through a benchmark survey.

Industries Profiled:
Pharmaceutical; Biotech; Biopharmaceutical; Medical Device; Manufacturing; Consumer Products; Diagnostic; Health Care; Service; Chemical; Clinical Research; Laboratories


Companies Profiled:
AbbVie; Amgen; Apellis Pharmaceuticals; Astellas; AstraZeneca; Baxter International; Bayer; Biogen Idec; Boehringer Ingelheim; B. Braun; Cara Therapeutics; Chiesi; Cipla; Daiichi Sankyo; Eisai; Eli Lilly and Company; EVERSANA; Fidia; Genentech; General Electric; Gilead Sciences; GlaxoSmithKline ; Heron Therapeutics; Ipsen; Jazz Pharmaceuticals; Kyowa Kirin; Lupin; Lundbeck; Medexus Pharmaceuticals; Merck; Novartis; Novo Nordisk; Orchard Therapeutics; Pixacore; Provention Bio; Radius Health; Inc.; Roche; Sandoz; Sanofi; Santen; Supernus; Takeda Pharmaceuticals; Taysha Gene Therapies

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

RELATED RESEARCH